Figure 1a.
Figure 1a. Bortezomib down-regulates HLA-class I expression on patient myeloma cells.

Bortezomib down-regulates HLA-class I expression on patient myeloma cells.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal